Total Holdings
57
Portfolio diversification across 57 positions
PBPH
(NASDAQ)Portfolio Building Block World Pharma and Biotech Index ETF
$25.61-- (--)
Loading... - Market loading
PBPH ETF Holdings: Portfolio Building Block World Pharma and Biotech Index ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$718.65M
Total fund assets
Expense Ratio
0.13%
Annual management fee
Fund Issuer
Portfolio Building Block
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 15.57% |
| 2 |  | Johnson & Johnson | Stock | 9.42% |
| 3 |  | AbbVie Inc | Stock | 6.92% |
| 4 | S SWX:ROG | Roche Holding AG | Stock | 5.01% |
| 5 |  | Merck & Co., Inc. | Stock | 4.81% |
| 6 | S SWX:NOVN | Novartis AG | Stock | 4.79% |
| 7 | L LON:AZN | AstraZeneca PLC | Stock | 4.78% |
| 8 | L LSE:AZN | AstraZeneca PLC | Stock | 4.65% |
| 9 |  | Gilead Sciences, Inc. | Stock | 4.44% |
| 10 | S SWX:ROP | Roche Holding AG | Stock | 4.44% |
| 11 |  | Amgen Inc. | Stock | 4.28% |
| 12 |  | Pfizer Inc. | Stock | 4.13% |
| 13 | L LSE:0QIU | Novo Nordisk A/S Class B | Stock | 3.97% |
| 14 | B BMY | Bristol-Myers Squibb Company | Stock | 3.11% |
| 15 | C CPH:NOVO.B | Novo Nordisk A/S | Stock | 2.99% |
| 16 |  | Vertex Pharmaceuticals Incorporated | Stock | 2.85% |
| 17 | L LON:GSK | GSK plc | Stock | 2.72% |
| 18 | E EPA:SAN | Sanofi | Stock | 2.67% |
| 19 | L LSE:GSK | GlaxoSmithKline plc | Stock | 2.29% |
| 20 |  | Regeneron Pharmaceuticals, Inc. | Stock | 1.99% |
| 21 | T TYO:4502 | Takeda Pharmaceutical Company Limited | Stock | 1.46% |
| 22 | A ASX:CSL | CSL Limited | Stock | 1.36% |
| 23 |  | Zoetis Inc | Stock | 1.33% |
| 24 | E EBR:ARGX | Argen-X | Stock | 1.25% |
| 25 |  | Alnylam Pharmaceuticals, Inc | Stock | 1.18% |
| 26 | E ETR:BAYN | Bayer Aktiengesellschaft | Stock | 1.17% |
| 27 | T TSE:4502 | Takeda Pharmaceutical Co. Ltd. | Stock | 1.17% |
| 28 | L LSE:HLN | Haleon PLC | Stock | 1.04% |
| 29 | E EBR:UCB | UCB SA | Stock | 0.93% |
| 30 | T TYO:4519 | Chugai Pharmaceutical Co., Ltd. | Stock | 0.92% |
| 31 |  | Insmed Incorporated | Stock | 0.91% |
| 32 | T TLV:TEVA | Teva Pharmaceutical Industries Limited | Stock | 0.87% |
| 33 | T TSE:4568 | Daiichi Sankyo Co. Ltd. | Stock | 0.84% |
| 34 | T TA:TEVA | Teva Pharmaceutical Industries Ltd | Stock | 0.82% |
| 35 | T TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 0.79% |
| 36 |  | Natera, Inc | Stock | 0.74% |
| 37 | S SWX:SDZ | Sandoz Group AG | Stock | 0.73% |
| 38 | S SWX:GALD | Galderma Group N | Stock | 0.65% |
| 39 |  | Biogen Inc | Stock | 0.61% |
| 40 | T TSE:4578 | Otsuka Holdings Ltd | Stock | 0.57% |
| 41 | T TSE:4503 | Astellas Pharma Inc. | Stock | 0.57% |
| 42 |  | United Therapeutics Corporation | Stock | 0.51% |
| 43 |  | Incyte Corporation | Stock | 0.47% |
| 44 |  | Exact Sciences Corporation | Stock | 0.44% |
| 45 |  | Neurocrine Biosciences, Inc | Stock | 0.33% |
| 46 |  | Viatris Inc | Stock | 0.33% |
| 47 |  | Royalty Pharma plc | Stock | 0.32% |
| 48 |  | Revolution Medicines, Inc | Stock | 0.32% |
| 49 |  | Ionis Pharmaceuticals, Inc | Stock | 0.31% |
| 50 | T TSE:4507 | Shionogi & Co. Ltd. | Stock | 0.30% |
Frequently Asked Questions About Portfolio Building Block World Pharma and Biotech Index ETF Holdings
What are the top holdings in PBPH?
Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) holds 57 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is PBPH's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review PBPH's holdings table to analyze concentration risk.
What is PBPH's sector allocation?
The Sector Allocation chart shows how PBPH distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does PBPH invest in?
PBPH's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is PBPH ETF?
PBPH's diversification can be assessed by reviewing its 57 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.